Innocan Pharma Engages Pain-Management Expert Ahead of FDA Meeting

Innocan Pharma (INNO.CN) said Tuesday it engaged the Past-President of the Eastern Pain Association, Dr. William K. Schmidt, to support its LPT-CBD submission process to the Food and Drug Administrati

MT NewswiresJul 2 16:21 ET

Innocan Pharma Announces Successful Preliminary Safety Evaluation of LPT-CBD in Minipigs

Innocan Pharma (INNO.CN), on Tuesday said a preliminary safety evaluation of Innocan's single injection and sustained-release LPT-CBD conducted on minipigs showed the animals demonstrated excellent dr

MT NewswiresJun 11 16:30 ET

Innocan Pharma Reports First Quarter 2024 Results With Revenue Growth of Over 4X to $6.8 Million

Stockhouse May 27 16:00 ET

InnoCan Pharma Brief: FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain

04:02 PM EDT, 05/21/2024 (MT Newswires) -- InnoCan Pharma Brief: FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain

MT NewswiresMay 21 16:02 ET

Innocan Pharma to Participate in the White Label World Expo on February 27-28th, 2024

Stockhouse Feb 20 02:00 ET

Innocan Pharma Announces Promising LPT-CBD Safety Indications -Implications From a Prolong Use In...

Stockhouse Nov 3, 2023 16:00 ET